首页> 美国卫生研究院文献>The Journal of Clinical Investigation >Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states.
【2h】

Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states.

机译:蛋白C抗原与口服抗凝药期间和特定疾病状态下抗凝药活性之间的关系。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Protein C is a natural vitamin K-dependent plasma anticoagulant, deficiencies of which have been found in patients with recurrent thrombosis and warfarin-induced skin necrosis. To appreciate more fully the role of protein C in disease states and during oral anticoagulation, a new functional assay for protein C involving adsorption of plasma protein C on a Ca+2-dependent monoclonal antibody, elution, quantitative activation, and assessment of plasma anticoagulant activity, has been developed. When oral anticoagulation is initiated, the anticoagulant activity of protein C decreases to a greater extent than either the amidolytic or immunologic levels. During stabilized warfarin treatment, there is no correlation between either amidolytic or antigenic levels and the functional protein C activity, suggesting that measurement of protein C anticoagulant activity may be necessary to reflect adequately the anticoagulant protection afforded by this protein. In contrast, there was a strong correlation between anticoagulant and amidolytic and immunologic levels in liver failure and disseminated intravascular coagulation. Two patients with thromboembolic disease have been identified who exhibit a marked decrease in anticoagulant activity, but who have normal immunologic and amidolytic levels. Thus, this assay permits assessment of protein C in individuals who have received anticoagulant treatment and identification of a new class of protein C-deficient individuals.
机译:蛋白C是天然的维生素K依赖型血浆抗凝剂,在反复出现血栓形成和华法林诱导的皮肤坏死的患者中发现了其缺陷。为了更全面地了解蛋白C在疾病状态和口服抗凝过程中的作用,对蛋白C进行了一项新的功能测定,包括将血浆蛋白C吸附在依赖Ca + 2的单克隆抗体上,进行洗脱,定量活化以及评估血浆抗凝剂活动,已经开发。当开始口服抗凝时,蛋白C的抗凝活性下降的幅度大于酰胺化或免疫学水平。在稳定的华法林治疗期间,酰胺分解或抗原水平与功能性蛋白C活性之间没有相关性,这表明可能需要测量蛋白C抗凝活性才能充分反映该蛋白提供的抗凝保护作用。相反,肝衰竭和弥散性血管内凝血的抗凝和酰胺分解及免疫学水平之间有很强的相关性。已确定两名血栓栓塞性疾病患者的抗凝活性明显下降,但免疫和酰胺分解水平正常。因此,该测定法允许评估接受抗凝治疗的个体中的C蛋白,并鉴定出一类新的C蛋白缺陷型个体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号